Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies-Reference-Cited by-同舟云学术

Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies

Published:2021-01-01 Issue:1 Volume:36 Page:1732-1750
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Alanazi Mohammed M.¹^ORCID,Elwan Alaa²^ORCID,Alsaif Nawaf A.¹^ORCID,Obaidullah Ahmad J.¹^ORCID,Alkahtani Hamad M.¹^ORCID,Al-Mehizia Abdulrahman A.¹^ORCID,Alsubaie Sultan M.¹,Taghour Mohammed S.²^ORCID,Eissa Ibrahim H.²^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2. Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1945591

Reference85 articles.

1. AACR Cancer Progress Report 2015

2. WHO. Cancer. Available from: https://www.who.int/health-topics/cancer#tab=tab_1. [accessed May 2020].